AU694074B2 - Process for purifying macrocyclic chelating agents - Google Patents
Process for purifying macrocyclic chelating agentsInfo
- Publication number
- AU694074B2 AU694074B2 AU28563/97A AU2856397A AU694074B2 AU 694074 B2 AU694074 B2 AU 694074B2 AU 28563/97 A AU28563/97 A AU 28563/97A AU 2856397 A AU2856397 A AU 2856397A AU 694074 B2 AU694074 B2 AU 694074B2
- Authority
- AU
- Australia
- Prior art keywords
- purifying
- chelating agents
- macrocyclic chelating
- macrocyclic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86807892A | 1992-04-13 | 1992-04-13 | |
US868078 | 1992-04-13 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU42850/93A Division AU677006C (en) | 1992-04-13 | 1993-04-13 | Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2856397A AU2856397A (en) | 1997-10-30 |
AU694074B2 true AU694074B2 (en) | 1998-07-09 |
Family
ID=25351031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28563/97A Ceased AU694074B2 (en) | 1992-04-13 | 1997-07-09 | Process for purifying macrocyclic chelating agents |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0662842A1 (en) |
JP (1) | JPH07505886A (en) |
AU (1) | AU694074B2 (en) |
CA (1) | CA2117775A1 (en) |
NO (1) | NO943847L (en) |
SG (1) | SG52470A1 (en) |
WO (1) | WO1993020852A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE258806T1 (en) * | 1994-09-07 | 2004-02-15 | Dow Chemical Co | METHOD FOR PRODUCING MACROCYCLIC AGENTS AND THEIR CHELATES AND CONJUGATES |
JP5006032B2 (en) * | 2003-04-15 | 2012-08-22 | アルゲッタ エイエス | Use of thorium-227 in radiotherapy of soft tissue diseases |
US20090208421A1 (en) | 2008-02-19 | 2009-08-20 | Dominique Meyer | Process for preparing a pharmaceutical formulation of contrast agents |
JP5376130B2 (en) * | 2009-03-24 | 2013-12-25 | 独立行政法人日本原子力研究開発機構 | Separation and purification of carrier-free 177Lu capable of antibody labeling |
GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
US4994560A (en) * | 1987-06-24 | 1991-02-19 | The Dow Chemical Company | Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies |
IL90730A0 (en) * | 1988-06-24 | 1990-01-18 | Dow Chemical Co | Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates |
JP2930708B2 (en) * | 1988-12-23 | 1999-08-03 | ザ ダウ ケミカル カンパニー | Method for producing isothiocyanato-functionalized metal complex |
-
1993
- 1993-04-13 CA CA 2117775 patent/CA2117775A1/en not_active Abandoned
- 1993-04-13 EP EP93912231A patent/EP0662842A1/en not_active Ceased
- 1993-04-13 WO PCT/US1993/003483 patent/WO1993020852A2/en not_active Application Discontinuation
- 1993-04-13 JP JP5518572A patent/JPH07505886A/en active Pending
- 1993-04-13 SG SG1996004996A patent/SG52470A1/en unknown
-
1994
- 1994-10-12 NO NO943847A patent/NO943847L/en unknown
-
1997
- 1997-07-09 AU AU28563/97A patent/AU694074B2/en not_active Ceased
Non-Patent Citations (1)
Title |
---|
CHEMICAL ABSTRACTS 125 29606 120 49589 * |
Also Published As
Publication number | Publication date |
---|---|
JPH07505886A (en) | 1995-06-29 |
NO943847D0 (en) | 1994-10-12 |
WO1993020852A3 (en) | 1993-11-25 |
NO943847L (en) | 1994-10-12 |
SG52470A1 (en) | 1998-09-28 |
WO1993020852A2 (en) | 1993-10-28 |
CA2117775A1 (en) | 1993-10-28 |
AU677006B2 (en) | 1997-04-10 |
AU4285093A (en) | 1993-11-18 |
EP0662842A1 (en) | 1995-07-19 |
AU2856397A (en) | 1997-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU662088B2 (en) | Waste treatment process employing oxidation | |
AU7041494A (en) | Pollution reduction process | |
AU656457B2 (en) | Chemical process | |
AP9300593A0 (en) | Process | |
AU7384394A (en) | Chelating compounds | |
AU3529995A (en) | Purification process | |
GB2270870B (en) | Process for forming recesses | |
AU694074B2 (en) | Process for purifying macrocyclic chelating agents | |
AU3100793A (en) | Chemical process | |
GB9325468D0 (en) | Process for purifying polyols | |
AU3374393A (en) | Steam-drawing process for yarns | |
GB9206667D0 (en) | Purification process | |
HUT65321A (en) | Process for preparation of-n-acylated-p-phends | |
GB9202375D0 (en) | Process | |
HUT59897A (en) | Process for purifying vinyl-aromatic monomeres | |
EP0563986A3 (en) | Process for selective hydrodefluorination | |
EP0649408A4 (en) | Process for making phenylthiomethylpyridinylalkenoates. | |
GB9201496D0 (en) | Process | |
HU9204061D0 (en) | Purification method | |
AU6798694A (en) | Method for purifying chlorophenol-containing waters | |
AP9300473A0 (en) | Process | |
HU912694D0 (en) | Process for purifying 4-acet-oxy-styrene | |
GB2295821B (en) | Process for purifying chromium-containing wastewaters | |
IL91346A0 (en) | Process for purifying chromium-containing wastes | |
AU4973293A (en) | Anomerisation process |